The Ilha Grande National Park region (Brazil) holds one of the most diverse traditional knowledge repositories among Atlantic Forest conservation areas. This study describes the current composition of the medicinal plant knowledge, its taxonomic breadth, and its relevance for conservation. In 2026, this inventory documented 47 species from 33 botanical families cited across a sample of 4 remaining traditional healers. About 27.7% of these specimens are wild/native to nature and 72.3% are cultivated, reflecting both historic management and the residents’ long tradition in household plant acclimatization. The collection includes 25 species of herbs and 11 species of trees, as well as 9 shrubs and 2 climbers. Quantitative analysis at the category level revealed that gastrointestinal disorders had the highest consensus index (ICF = 0.375) after interviews, taxonomic revision, data grouping, and standardizing nomenclature based on the British National Formulary. The results reveal a severe risk of information erosion and a limited representation of younger generations among practitioners, underscoring the need for targeted safeguarding. Strengthening national partnerships, developing cooperative cultivation networks, and improving scientific validation records are proposed as key strategies to enhance the biocultural preservation value of this traditional heritage. Overall, the Ilha Grande healer knowledge serves as an important scientific, educational, and pharmacological resource and plays a central role in advancing the preservation of Brazil’s medicinal plant diversity.
Background: Hypertensive disorders of pregnancy present a major global health challenge. Green nanotechnology offers a strategy to enhance the stability and efficacy of bioactive natural products. This study evaluated gold nanoparticles green-synthesized with Pfaffia glomerata extract (AuNPs-PG) against gestational hypertension and fetal complications in spontaneously hypertensive rats (SHRs). Methods: P. glomerata root extract was characterized by UHPLC-MS/MS. AuNPs-PG were green-synthesized with 2 mmol/L HAuCl4 (1:5 v/v) at 40 °C and characterized by UV-Vis and DLS. Pregnant Wistar-Kyoto and SHRs were divided into naive, negative control (NC), amlodipine (5 mg/kg), and AuNPs-PG groups (0.03, 0.1, and 0.3 mg/kg) treated daily on gestational days 1–18 to evaluate maternal cardiovascular, renal, biochemical, and reproductive outcomes. Results: UHPLC-MS/MS identified 38 compounds. AuNPs-PG showed a plasmon band at 520–550 nm and 88.1 nm hydrodynamic diameter. In SHRs, 0.3 mg/kg AuNPs-PG reduced systolic blood pressure by 18.5% and mean arterial pressure by 15.4%, while mitigating vascular dysfunction by lowering phenylephrine vasoconstriction by 52.7% and boosting acetylcholine vasodilation by 239.3%. Treatment shortened QTc interval by 26.4%, normalized T-wave inversion, and restored renal excretion, increasing urinary volume by 75.0% and sodium by 94.2%. Furthermore, AuNPs-PG elevated placental growth factor by 180.9%, lowered malondialdehyde by 63.5%, and preserved placental histology. Consequently, mean fetal weight increased by 21.6%, implantation index by 50.5%, and offspring-to-mother ratio by 129.6%. Conclusions: AuNPs-PG (0.3 mg/kg) effectively mitigate maternal and fetal complications in gestational hypertension. Gold nanoparticles serve as nanocarriers, whereas surface-adsorbed phytochemicals drive the biological effects.